Theravance Biopharma Inc
F:0TB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Theravance Biopharma Inc
F:0TB
|
KY |
|
China BlueChemical Ltd
OTC:CBLUY
|
CN |
|
Southern Archipelago Ltd
SGX:A33
|
SG |
|
T
|
TROOPS Inc
F:SG5
|
KY |
|
Charter Hall Long WALE REIT
ASX:CLW
|
AU |
|
Aprea Therapeutics Inc
NASDAQ:APRE
|
US |
|
American Lithium Minerals Inc
OTC:AMLM
|
US |
|
A
|
Ashmore Group PLC
DUS:A1B
|
UK |
|
A
|
Albis Leasing AG
DUS:ALG
|
DE |
|
Viabuilt Ventures Inc
OTC:VBVT
|
US |
|
Heiwa Corp
F:HWC
|
JP |
|
Grupo Ezentis SA
MAD:EZE
|
ES |
|
K
|
KWG Group Holdings Ltd
SWB:KOU
|
CN |
|
P
|
Pacific Metals Co Ltd
SWB:PYV
|
JP |
|
T
|
Taylor Wimpey PLC
F:TWW
|
UK |
|
A
|
ASBISc Enterprises PLC
WSE:ASB
|
CY |
Bankruptcy Probability
Theravance Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Theravance Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KY |
|
Theravance Biopharma Inc
NASDAQ:TBPH
|
883.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
378.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
347.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
242.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
199.4B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
276.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
169.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Theravance Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Theravance Biopharma Inc has total debt of 32.8m USD. This includes both short-term (0 USD) and long-term (32.8m USD) debt.
You can find a full breakdown on its Balance Sheet.